Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
The authors used buspirone, a new anxiolytic agent that has a low side effect profile, to treat 14 developmentally disabled individuals who demonstrated anxiety as well as aggressive and self-injurious behaviors. Nine of the 14 individuals responded favorably to the drug. The authors present case reports for 3 of the responders and discuss the clinical implications of buspirone therapy.
Ratey
J J
JJ
Medifield State Hospital, Mass 02502.
Sovner
R
R
Mikkelsen
E
E
Chmielinski
H E
HE
D000275:Adjustment Disorders / Q000188:drug therapy / Q000523:psychology; D000328:Adult; D000374:Aggression / Q000187:drug effects*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy / Q000523:psychology* / Q000534:rehabilitation; D008297:Male; D008875:Middle Aged; D012652:Self Mutilation / Q000188:drug therapy*
D002065:Buspirone